Annette North

Entity
Individual
Business address
C/O Sgx Pharmaceuticals, Inc., 10505 Roselle Street, 92121 San Diego, CA
Insider ownership signature
/s/ Paolo Tombesi, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Annette North has filed 24 SEC EDGAR filings since 1/31/2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 SUBMISSION Feb 11, 2022 Feb 9, 2022 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Aug 31, 2021 Aug 30, 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Jun 16, 2021 Jun 15, 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION May 7, 2021 May 6, 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Mar 9, 2021 Mar 8, 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Feb 10, 2021 Feb 8, 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Feb 2, 2021 Feb 1, 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Jan 8, 2020 Jan 6, 2020 001-38871
3 Open Document Open Filing FORM 3 SUBMISSION Apr 16, 2019 Apr 16, 2019 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION Jan 24, 2019 Jan 22, 2019 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION Jan 26, 2018 Jan 24, 2018 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION Jan 25, 2017 Jan 23, 2017 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION Feb 2, 2016 Jan 29, 2016 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION Apr 27, 2015 Apr 23, 2015 000-53058
3 Open Document Open Filing FORM 3 SUBMISSION Mar 16, 2015 Mar 6, 2015 000-53058
4 Open Document Open Filing PRIMARY DOCUMENT Nov 12, 2014 Nov 10, 2014 001-35919
4 Open Document Open Filing 4 May 19, 2014 May 15, 2014 001-35919
4 Open Document Open Filing FORM 4 Jan 10, 2014 Jan 8, 2014 001-35919